Clinical Trial Update: Secretin-enhanced Magnetic Resonance Imaging (S-MRI) for Pancreatic Cancer Detection [NA]

View source ↗

Summary

A clinical trial evaluating secretin-enhanced MRI for pancreatic cancer detection has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraductal Papillary Mucinous Neoplasm
• Pancreatic Cancer

Snippet

Sponsor: Elizabeth Hecht | Conditions: Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm | NA | Status: WITHDRAWN